Joannidis, Michael http://orcid.org/0000-0002-6996-0881
Forni, Lui G.
Klein, Sebastian J.
Honore, Patrick M.
Kashani, Kianoush
Ostermann, Marlies
Prowle, John
Bagshaw, Sean M.
Cantaluppi, Vincenzo
Darmon, Michael
Ding, Xiaoqiang
Fuhrmann, Valentin
Hoste, Eric
Husain-Syed, Faeq
Lubnow, Matthias
Maggiorini, Marco
Meersch, Melanie
Murray, Patrick T.
Ricci, Zaccaria
Singbartl, Kai
Staudinger, Thomas
Welte, Tobias
Ronco, Claudio
Kellum, John A.
Funding for this research was provided by:
Astute Medical
Baxter
CLS Behring
Cytosorb
HepaWash
NxStage
Article History
Received: 9 September 2019
Accepted: 13 November 2019
First Online: 9 December 2019
Compliance with ethical standards
:
: MJ has received honoraria and research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius, and Astute Medical. LGF has received honoraria and research support from Astute Medical, La Jolla Pharmaceuticals, Medibeacon, Baxter, and Fresenius. PMH has received honoraria and research support from Baxter and CytoSorbent. MO has received honoraria from Fresenius Medical and Baxter and has an advisory role to Biomerieux and Nxstage. JP has received speaker’s honoraria from Fresenius Medical, Baxter and Nikkiso, research support from Biomerieux and Abbott, and has consulted for Nikkiso, Baxter, Medibeacon and Quark Pharma. SMB has consulted and received research support from Baxter Health Care. MD has received research support from MSD and from ASTUTE medical, speaker fees from MSD, Astellas and Bristol-Myers-Squibb, support to organize educational meetings from MSD, Astellas, and Jazz Pharma and has participated in an advisory board from SANOFI-AVENTIS. VF has received honoraria from HepaWash. EH has received speaker’s fee and travel fee from Alexion, AM Pharma, Sopachem, and Bellco. M. Maggiorini has a MAB membership from Baxter and has received an unrestricted research grant from Baxter. M. Meersch has received lecture fees from Astute Medical, Fresenius Medical and Baxter. PTM has advisory board memberships with FAST Biomedical, AM-Pharma, Sphingotec. TS has an advisory board membership with Xenios and has received speaker fees from Getinge, Xenios, Zoll, Orion Pharma, and Fresenius. JAK has received consulting fees and research support from Astute Medical, Baxter and Fresenius. None of the other authors have any conflicts of interest to declare with regard to this manuscript.